|
|
|
 Search Articles in 'News' Category
|
 |
- MILLIPORE BUYS REMAINING OWNERSHIP OF JV IN INDIA
Millipore India was first established as a joint venture in 1988
[12/18/2009]
Millipore India, Biotechnology, Pharmaceutical, Life Science Research Industries, Dr. Martin Madaus, Access Services Lab, Drug Manufacturers, President of Millipore India, Vaccines, Food and Drug Administration, Global Generic Drug Market, Biotechnology Industries, Biopharmaceutical Industry
- MALVINDER SINGH EXITS RANBAXY, DAIICHI IN COMPLETE CONTROL
It is learned he will look after the family's other business interests - Fortis chain of hospitals and Religere finance group...
[5/29/2009]
CEO and Managing Director of Ranbaxy, Malvinder Singh, Indias largest pharma company, Daiichi Sankyo, Bhai Mohan Singh, Mr. Atul Sobti, Ranbaxy Chief Operating Officer, Dr. Tsutomu Une, Non-executive Director of Ranbaxy, Board Meeting of Ranbaxy, CEO of Daiichi Sankyo, Local Indian company, Large multi-national company, Senior Executive Officer, Member of the Board of Daiichi Sankyo, Fortis chain of hospitals, Religere finance group, Life and non life insurance, Mutual funds, Financial services
- GIS, ROCHE NIMBLEGEN DEVELOP APPROACH TO IDENTIFY H1N1 VIRUS
A novel approach to uncover the complete sequence of any influenza A virus with just a quick nasal swab or nasal pharyngeal wash from patients...
[5/29/2009]
A STAR Genome Institute of Singapore, Dr Christopher Wong, Roche NimbleGen, Polymerase chain reaction (PCR), NimbleGen unique microarray-based platform, RNA (ribonucleic acid) material, PCR-based diagnostics, PCR technology, Detecting of pathogens, Prof Edison Liu, GIS Executive Director
- GENE SCREEN MAY PREDICT COLON CANCER'S RETURN
First genomic test aimed at predicting colon cancer recurrence may help individualize treatment for patients, leading to less toxic and more targeted therapy choices...
[5/17/2009]
Oncotype DX test, Stage II colon cancer, Forgo sometimes toxic, Costly chemotherapy, American Society of Clinical Oncology (ASCO), Chemotherapy, Dr. David Kerr, Professor of cancer medicine, University of Oxford, Dr. Richard L. Schilsky, President of ASCO, Professor of medicine, University of Chicago, Clinical decision-making process
- HEART RESULTS SHOW PROMISE FOR MESOBLAST
MESOBLAST says the three-month interim results of the company’s Phase 2 clinical trial of its stem cell treatment for congestive heart failure show the product leads to significantly improved heart muscle function in patients.
[5/17/2009]
Revascor, Damaged heart muscle, Improved ejection fraction, Mesoblast, Mesoblast United States-based associated company, Angioblast Systems, Moderate-severe congestive heart failure, Echocardiogram, Lowest dose of Revascor, Professor Silviu Itescu, Monash University Centre of Cardiovascular Research and Education in Therapeutics, Professor Henry Krum, Chronic heart failure
- VEREDUS'S VEREFLU TO DETECT CURRENT STRAIN OF SWINE FLU H1N1
VereFlu is a portable lab-on-chip application for rapid detection of all major influenza types at the point of need
[5/11/2009]
VereFlu, Veredus Laboratories, Swine Flu, VereID Biosystem, STMicroelectronics, Polymerase Chain Reaction, Veredus, Dr Rosemary Tan
|
PAGE: 1
Total 'Article' available now: 6 |
| |
|
|
